Peak6 Investments LLC Biotechnology

Peak6 Investments LLC

  • $43.5 Billion
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
BNTX
Bio N Tech Se
CALL
$26.5 Million
223K
Q2 2024
Added 180.19%
MRNA
Moderna, Inc.
PUT
$16.1 Million
241K
Q3 2024
Reduced 45.78%
NVO
Novo Nordisk A S
PUT
$12.3 Million
104K
Q3 2024
New holding
REGN
Regeneron Pharmaceuticals, Inc.
PUT
$11.6 Million
11K
Q1 2024
Added 100.0%
ALNY
Alnylam Pharmaceuticals, Inc.
PUT
$8.47 Million
30.8K
Q3 2024
Reduced 77.93%
ALNY
Alnylam Pharmaceuticals, Inc.
CALL
$8.17 Million
29.7K
Q3 2024
Reduced 77.93%
SRPT
Sarepta Therapeutics, Inc.
CALL
$5.58 Million
44.7K
Q2 2023
New holding
VKTX
Viking Therapeutics, Inc.
CALL
$4.48 Million
70.8K
Q2 2024
Added 38.08%
CRSP
Crispr Therapeutics Ag
CALL
$4.27 Million
90.9K
Q3 2024
New holding
IONS
Ionis Pharmaceuticals Inc
CALL
$4.01 Million
100K
Q3 2024
Reduced 10.01%
VRTX
Vertex Pharmaceuticals Inc
CALL
$3.72 Million
8K
Q3 2024
Added 8200.0%
SRPT
Sarepta Therapeutics, Inc.
PUT
$3.68 Million
29.5K
Q2 2023
New holding
MRNA
Moderna, Inc.
CALL
$3.22 Million
48.2K
Q3 2024
Reduced 45.78%
ARGX
Argenx Se
CALL
$3.2 Million
5.9K
Q3 2024
Reduced 99.8%
BNTX
Bio N Tech Se
PUT
$2.28 Million
19.2K
Q2 2024
Added 180.19%
CYTK
Cytokinetics Inc
CALL
$1.86 Million
35.3K
Q3 2024
Reduced 25.33%
BBIO
Bridge Bio Pharma, Inc.
CALL
$1.39 Million
54.5K
Q2 2024
Reduced 20.32%
BPMC
Blueprint Medicines Corp
PUT
$1.37 Million
14.8K
Q3 2024
New holding
NVO
Novo Nordisk A S
CALL
$1.19 Million
10K
Q3 2024
New holding
ARGX
Argenx Se
PUT
$921,000
1.7K
Q3 2024
Reduced 99.8%
CYTK
Cytokinetics Inc
PUT
$712,000
13.5K
Q3 2024
Reduced 25.33%
NTLA
Intellia Therapeutics, Inc.
PUT
$616,000
30K
Q2 2024
Reduced 76.77%
NTLA
Intellia Therapeutics, Inc.
CALL
$581,000
28.3K
Q2 2024
Reduced 76.77%
INCY
Incyte Corp
PUT
$542,000
8.2K
Q3 2024
Reduced 68.09%
DNLI
Denali Therapeutics Inc.
CALL
$492,000
16.9K N/A
RARE
Ultragenyx Pharmaceutical Inc.
CALL
$472,000
8.5K
Q2 2023
New holding
SMMT
Summit Therapeutics Inc.
PUT
$438,000
20K
Q3 2024
New holding
CRSP
Crispr Therapeutics Ag
PUT
$399,000
8.5K
Q3 2024
New holding
MDGL
Madrigal Pharmaceuticals, Inc.
CALL
$360,000
1.7K
Q3 2024
New holding
EDIT
Editas Medicine, Inc.
CALL
$341,000
100K
Q3 2024
Reduced 35.88%
INSM
Insmed Inc
PUT
$328,000
4.5K N/A
STRO
Sutro Biopharma, Inc.
CALL
$259,000
75K
Q3 2024
New holding
VKTX
Viking Therapeutics, Inc.
PUT
$234,000
3.7K
Q2 2024
Added 38.08%
IMCR
Immunocore Holdings PLC
PUT
$233,000
7.5K
Q2 2024
New holding
VRTX
Vertex Pharmaceuticals Inc
PUT
$232,000
500
Q3 2024
Added 8200.0%
AKRO
Akero Therapeutics, Inc.
PUT
$220,000
7.7K N/A
BCYC
Bicycle Therapeutics PLC
CALL
$181,000
8K
Q3 2024
Reduced 5.34%
XENE
Xenon Pharmaceuticals Inc.
CALL
$145,000
3.7K
Q2 2024
New holding
BMRN
Biomarin Pharmaceutical Inc
PUT
$140,000
2K
Q3 2024
Reduced 48.96%
VERV
Verve Therapeutics, Inc.
PUT
$121,000
25K
Q3 2023
New holding
PTGX
Protagonist Therapeutics, Inc
CALL
$49,000
1.1K
Q2 2024
Added 43.0%
GHRS
Gh Research PLC
PUT
$17,000
2.6K
Q3 2024
Added 29.97%
Filter Shares Options
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email